HomeDiabetesDiabetes Book 3.1- Sulfonylureas. 1st generation medicine- Gujarati
Diabetes Book 3.1- Sulfonylureas. 1st generation medicine- Gujarati
$0.00
This book is one of the series of books on latest medications in relation to high blood sugar and diabetes.
Diabetes is so common and for the same reason there has been huge research in management and treatment of diabetes.
It is simple economics for research drug companies as diabetes is so common. If they make a new medicine, it will make the company very rich.
While drug companies are making new medications may be very rich, but it will keep us very healthy.
If our blood sugar is becoming higher, we can delay diabetes and complications by 30 years if we start management early.
This book introduces us to the new generation of sulfonylureas which help our body to increase the amount of insulin available to us.
Same description applies to book 3.1 diabetes also. We have just seen the number of the book. This book tells you about first generation sulfonylureas which is a group of medicines which helps our body to release and make available more insulin.
$0.00
ఈ పుస్తకం క్రింది ప్రశ్నలకు సమాధానాలను అందిస్తుంది:
• సాధారణ రక్తంలో చక్కెర అంటే ఏమిటి?
• మాకు ఎప్పుడు డయాలసిస్ అవసరం?
• భారతదేశంలో కిడ్నీ మార్పిడి సాధ్యమేనా?
• మీ చక్కెర స్థాయిని ఎలా నిర్వహించవచ్చు?Add to cart
Diabetes is a metabolic disorder, where the body does not produce insulin or does not use it efficiently, resulting in high blood sugar.
High blood sugar further increases the risk of kidney failure, blindness, amputation of legs (due to loss of sensations), and even heart attack.
Today we have 13 groups of excellent diabetes medications, which can really keep us very healthy.
This book talks about the role of the medications group called "Selective Sodium-Glucose Transporter-2 (SGLT2) Inhibitors" in diabetes management, covering important facts about them.
It further talks about Farxiga – a new medicine to improve Blood Sugar Control.
It also throws light on the four medications that come under this group Canagliflozin, Dapagliflozin, Empagliflozin, and Ertugliflozin
Reviews
There are no reviews yet.